Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates?

Jaeil Shin, Ran Namgung, Min Soo Park, Chul Lee

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

To assess whether lipid infusion could be a risk factor for parenteral nutrition-associated cholestasis (PNAC) in low birth weight neonates, 22 newborns with cholestasis (29.8±1.6 weeks, 1298±217 g) were compared with 22 without cholestasis (29.5±1.7 weeks, 1286±363 g). The mean level of peak direct bilirubin for the cholestasis group was 4.6 mg/dl compared to 1.2 mg/dl for the noncholestasis group. A univariate analysis revealed that PNAC was significantly related to duration of fasting (p=0.008) and parenteral nutrition (p<0.0001), days of antibiotics use (p=0.025), positive C-reactive protein (p=0.018) or gastric culture (p=0.018), and feeding intolerance (p<0.0001). Total amino acid amount (p<0.0001), total lipid amount (p<0.0001), and average daily lipid amount (p=0.002) were significantly higher in the cholestasis group than in the noncholestasis group. Conversely, prenatal administration of dexamethasone was a significant protective factor of PNAC (p=0.008). Logistic regression analysis revealed that the cumulative amount of lipid infusion was an independent risk factor for PNAC (p=0.041; OR 1.174; CI 1.007-1.369). We suggest that decreasing the cumulative load of amino acids and intralipids with early trophic feeding, control of infection, and prenatal administration of dexamethasone could possibly attenuate the severity of PNAC.

Original languageEnglish
Pages (from-to)197-202
Number of pages6
JournalEuropean Journal of Pediatrics
Volume167
Issue number2
DOIs
Publication statusPublished - 2008 Feb 1

Fingerprint

Cholestasis
Parenteral Nutrition
Low Birth Weight Infant
Newborn Infant
Lipids
Dexamethasone
Amino Acids
Infection Control
Bilirubin
C-Reactive Protein
Fasting
Stomach
Logistic Models
Regression Analysis
Anti-Bacterial Agents

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{f6ee073ebc5c4c42ad6c790b6ec86fbe,
title = "Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates?",
abstract = "To assess whether lipid infusion could be a risk factor for parenteral nutrition-associated cholestasis (PNAC) in low birth weight neonates, 22 newborns with cholestasis (29.8±1.6 weeks, 1298±217 g) were compared with 22 without cholestasis (29.5±1.7 weeks, 1286±363 g). The mean level of peak direct bilirubin for the cholestasis group was 4.6 mg/dl compared to 1.2 mg/dl for the noncholestasis group. A univariate analysis revealed that PNAC was significantly related to duration of fasting (p=0.008) and parenteral nutrition (p<0.0001), days of antibiotics use (p=0.025), positive C-reactive protein (p=0.018) or gastric culture (p=0.018), and feeding intolerance (p<0.0001). Total amino acid amount (p<0.0001), total lipid amount (p<0.0001), and average daily lipid amount (p=0.002) were significantly higher in the cholestasis group than in the noncholestasis group. Conversely, prenatal administration of dexamethasone was a significant protective factor of PNAC (p=0.008). Logistic regression analysis revealed that the cumulative amount of lipid infusion was an independent risk factor for PNAC (p=0.041; OR 1.174; CI 1.007-1.369). We suggest that decreasing the cumulative load of amino acids and intralipids with early trophic feeding, control of infection, and prenatal administration of dexamethasone could possibly attenuate the severity of PNAC.",
author = "Jaeil Shin and Ran Namgung and Park, {Min Soo} and Chul Lee",
year = "2008",
month = "2",
day = "1",
doi = "10.1007/s00431-007-0454-7",
language = "English",
volume = "167",
pages = "197--202",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Verlag",
number = "2",

}

Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates? / Shin, Jaeil; Namgung, Ran; Park, Min Soo; Lee, Chul.

In: European Journal of Pediatrics, Vol. 167, No. 2, 01.02.2008, p. 197-202.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates?

AU - Shin, Jaeil

AU - Namgung, Ran

AU - Park, Min Soo

AU - Lee, Chul

PY - 2008/2/1

Y1 - 2008/2/1

N2 - To assess whether lipid infusion could be a risk factor for parenteral nutrition-associated cholestasis (PNAC) in low birth weight neonates, 22 newborns with cholestasis (29.8±1.6 weeks, 1298±217 g) were compared with 22 without cholestasis (29.5±1.7 weeks, 1286±363 g). The mean level of peak direct bilirubin for the cholestasis group was 4.6 mg/dl compared to 1.2 mg/dl for the noncholestasis group. A univariate analysis revealed that PNAC was significantly related to duration of fasting (p=0.008) and parenteral nutrition (p<0.0001), days of antibiotics use (p=0.025), positive C-reactive protein (p=0.018) or gastric culture (p=0.018), and feeding intolerance (p<0.0001). Total amino acid amount (p<0.0001), total lipid amount (p<0.0001), and average daily lipid amount (p=0.002) were significantly higher in the cholestasis group than in the noncholestasis group. Conversely, prenatal administration of dexamethasone was a significant protective factor of PNAC (p=0.008). Logistic regression analysis revealed that the cumulative amount of lipid infusion was an independent risk factor for PNAC (p=0.041; OR 1.174; CI 1.007-1.369). We suggest that decreasing the cumulative load of amino acids and intralipids with early trophic feeding, control of infection, and prenatal administration of dexamethasone could possibly attenuate the severity of PNAC.

AB - To assess whether lipid infusion could be a risk factor for parenteral nutrition-associated cholestasis (PNAC) in low birth weight neonates, 22 newborns with cholestasis (29.8±1.6 weeks, 1298±217 g) were compared with 22 without cholestasis (29.5±1.7 weeks, 1286±363 g). The mean level of peak direct bilirubin for the cholestasis group was 4.6 mg/dl compared to 1.2 mg/dl for the noncholestasis group. A univariate analysis revealed that PNAC was significantly related to duration of fasting (p=0.008) and parenteral nutrition (p<0.0001), days of antibiotics use (p=0.025), positive C-reactive protein (p=0.018) or gastric culture (p=0.018), and feeding intolerance (p<0.0001). Total amino acid amount (p<0.0001), total lipid amount (p<0.0001), and average daily lipid amount (p=0.002) were significantly higher in the cholestasis group than in the noncholestasis group. Conversely, prenatal administration of dexamethasone was a significant protective factor of PNAC (p=0.008). Logistic regression analysis revealed that the cumulative amount of lipid infusion was an independent risk factor for PNAC (p=0.041; OR 1.174; CI 1.007-1.369). We suggest that decreasing the cumulative load of amino acids and intralipids with early trophic feeding, control of infection, and prenatal administration of dexamethasone could possibly attenuate the severity of PNAC.

UR - http://www.scopus.com/inward/record.url?scp=37549021472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37549021472&partnerID=8YFLogxK

U2 - 10.1007/s00431-007-0454-7

DO - 10.1007/s00431-007-0454-7

M3 - Article

VL - 167

SP - 197

EP - 202

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 2

ER -